SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $116 | – | 89 | +7.2% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 83 | -42.0% | 0.00% | – |
| Q3 2022 | $1,000 | -94.1% | 143 | -95.2% | 0.00% | – |
| Q1 2022 | $17,000 | +112.5% | 3,000 | +124.7% | 0.00% | – |
| Q4 2021 | $8,000 | -85.5% | 1,335 | -78.2% | 0.00% | – |
| Q3 2021 | $55,000 | -24.7% | 6,135 | 0.0% | 0.00% | – |
| Q2 2021 | $73,000 | -5.2% | 6,135 | 0.0% | 0.00% | – |
| Q1 2021 | $77,000 | -19.8% | 6,135 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $96,000 | +81.1% | 6,135 | +9.8% | 0.00% | – |
| Q3 2020 | $53,000 | +341.7% | 5,585 | +334.6% | 0.00% | – |
| Q2 2020 | $12,000 | +50.0% | 1,285 | +2.8% | 0.00% | – |
| Q1 2020 | $8,000 | 0.0% | 1,250 | +25.0% | 0.00% | – |
| Q4 2019 | $8,000 | -11.1% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -18.2% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $11,000 | +120.0% | 1,000 | +94.2% | 0.00% | – |
| Q1 2019 | $5,000 | -16.7% | 515 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -33.3% | 515 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | -25.0% | 515 | -41.1% | 0.00% | – |
| Q2 2018 | $12,000 | +33.3% | 875 | +80.4% | 0.00% | – |
| Q1 2018 | $9,000 | -52.6% | 485 | -58.2% | 0.00% | – |
| Q4 2017 | $19,000 | +11.8% | 1,160 | 0.0% | 0.00% | – |
| Q3 2017 | $17,000 | +70.0% | 1,160 | 0.0% | 0.00% | – |
| Q2 2017 | $10,000 | 0.0% | 1,160 | -42.0% | 0.00% | – |
| Q1 2017 | $10,000 | -16.7% | 2,000 | -23.1% | 0.00% | – |
| Q3 2016 | $12,000 | -96.0% | 2,600 | -94.9% | 0.00% | -100.0% |
| Q2 2016 | $297,000 | +130.2% | 51,300 | +140.8% | 0.00% | +100.0% |
| Q1 2016 | $129,000 | -50.0% | 21,300 | -8.6% | 0.00% | -50.0% |
| Q2 2015 | $258,000 | -29.3% | 23,300 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $365,000 | +9.0% | 23,300 | +5.9% | 0.01% | 0.0% |
| Q4 2014 | $335,000 | +41.4% | 22,000 | 0.0% | 0.01% | +66.7% |
| Q3 2014 | $237,000 | -29.5% | 22,000 | 0.0% | 0.00% | -40.0% |
| Q2 2014 | $336,000 | -15.6% | 22,000 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $398,000 | +30.1% | 22,000 | 0.0% | 0.01% | +50.0% |
| Q4 2013 | $306,000 | +32.5% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $231,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |